- Home
- TOVX vs RSLS Comparison
TOVX vs RSLS Comparison
Compare TOVX & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- RSLS
- Stock Information
- Founded
- TOVX 2001
- RSLS 2002
- Country
- TOVX United States
- RSLS United States
- Employees
- TOVX N/A
- RSLS N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- RSLS Medical/Dental Instruments
- Sector
- TOVX Health Care
- RSLS Health Care
- Exchange
- TOVX Nasdaq
- RSLS Nasdaq
- Market Cap
- TOVX 3.8M
- RSLS 4.5M
- IPO Year
- TOVX 2006
- RSLS 2007
- Fundamental
- Price
- TOVX $0.47
- RSLS $4.18
- Analyst Decision
- TOVX Hold
- RSLS Hold
- Analyst Count
- TOVX 1
- RSLS 1
- Target Price
- TOVX N/A
- RSLS N/A
- AVG Volume (30 Days)
- TOVX 1.8M
- RSLS 3.1M
- Earning Date
- TOVX 05-14-2025
- RSLS 05-21-2025
- Dividend Yield
- TOVX N/A
- RSLS N/A
- EPS Growth
- TOVX N/A
- RSLS N/A
- EPS
- TOVX N/A
- RSLS N/A
- Revenue
- TOVX N/A
- RSLS $7,175,000.00
- Revenue This Year
- TOVX N/A
- RSLS $52.80
- Revenue Next Year
- TOVX N/A
- RSLS N/A
- P/E Ratio
- TOVX N/A
- RSLS N/A
- Revenue Growth
- TOVX N/A
- RSLS N/A
- 52 Week Low
- TOVX $0.40
- RSLS $4.03
- 52 Week High
- TOVX $7.37
- RSLS $414.99
- Technical
- Relative Strength Index (RSI)
- TOVX 29.91
- RSLS 38.80
- Support Level
- TOVX $0.43
- RSLS $4.03
- Resistance Level
- TOVX $0.54
- RSLS $8.29
- Average True Range (ATR)
- TOVX 0.05
- RSLS 0.77
- MACD
- TOVX 0.03
- RSLS 0.24
- Stochastic Oscillator
- TOVX 41.18
- RSLS 3.52
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.